期刊文献+

受体型酪氨酸磷酸酶J抑制血管内皮细胞增殖及迁移 被引量:1

Inhibition effect of PTPRJ over-expression on proliferation and migration of vascular endothelial cells
下载PDF
导出
摘要 目的分析受体型酪氨酸磷酸酶J(PTPRJ)过表达对血管内皮细胞增殖及迁移活性的影响及机制。方法使用PTPRJ质粒转染人脐静脉内皮细胞(HUVEC)细胞。使用Western blot、RT-PCR、免疫荧光检测HUVEC细胞中PTPRJ表达情况,Western blot检测ERK1/2激酶磷酸化情况,RTPCR检测血小板源性生长因子-B(PDGF-B)的表达变化,Brd U摄入法检测细胞增殖率,划痕法检测细胞迁移率变化。结果免疫荧光检测质粒转染后HUVEC细胞中PTPRJ表达定位于细胞膜;PTPRJ质粒转染后ERK1/2激酶磷酸化受抑制,PDGF-B mRNA表达减少;PTPRJ质粒转染组细胞增殖率较空质粒组下降,差异有统计学意义(P=0.004)。PTPRJ质粒转染组细胞迁移率较空质粒组下降,差异有统计学意义(P=0.002)。结论 PTPRJ通过下调PDGF-B表达、抑制ERK1/2激酶磷酸化,对血管内皮细胞增殖及迁移活性具有负性调控作用。 Objective To investigate the effect of PTPRJ over-expression on cell proliferation and migration of vascular endothelial cells.Methods HUVEC cells were transfected by PTPRJ plasmids.PTPRJ expression was detected by immunofluorescence,Western blot and RT-PCR.ERK1/2 phosphorylation was measured by Western blot.Expression of PDGF-B was detected by RT-PCR.Cell proliferation rate was measured by BrdU nuclear incorporation assay.Cell migration rate was detected by wound healing assay.Results Immunofluorescence showed that PTPRJ was mainly distributed in cell membrane after PTPRJ plasmids transfection.ERK1/2 phosphorylation was inhibited and PDGF-B mRNA was down-regulated by PTPRJ plasmids transfection.Cell proliferation rate decreased after PTPRJ-WT transfection compared with empty vector transfection (P =0.004).Cell migration rate decreased after PTPRJ-WT transfection compared with empty vector transfection (P =0.002).Conclusion PTPRJ has critical negative influence on cell proliferation and migration of HUVEC cells by reversing ERK1/2 activation and inhibiting PDGF-B expression.
出处 《安徽医科大学学报》 CAS 北大核心 2014年第12期1730-1735,共6页 Acta Universitatis Medicinalis Anhui
基金 南京军区科研基金(编号:11MA102) 南京总医院科研基金(编号:2010Q005)
关键词 血管发生 PTPRJ PDGF-B 细胞增殖 细胞迁移 angiogenesis PTPRJ PDGF-B cell proliferation cell adhesion
  • 相关文献

参考文献13

  • 1Autschbach F, Palou E, Mechtersheimer G, et al. Expression of the membrane protein tyrosine phosphatase CD148 in human tis- sues [ J ]. Tissue Antigens, 1999,54 ( 5 ) :485 - 98.
  • 2Persson C, Engstrom U, Mowbray S, et al. Primary sequence de- terminants responsible for site-selective dephosphorylation of the PDGF beta-receptor by the receptor-like protein tyrosine phospha- tase DEP-1 [ J ]. FEBS Lett, 2002,517 ( 1 - 3 ) :27 - 31.
  • 3Takahashi T, Takahashi K, St John P L, et al. A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular develop- ment [J]. Mol Cell Biol, 2003,23(5) :1817 -31.
  • 4Carmeliet P, Jain R K. Molecular mechanisms and clinical appli- cations of angiogenesis [ J ]. Nature, 2011,473 ( 7347 ) : 298 - 307.
  • 5Saceo F, Tinti M, Palma A, et al. Tumor suppressor density-en- hanced phosphatase-1 ( DEP-1 ) inhibits the RAS pathway by di- rect dephnsphorylation of ERKI/2 kinases [ J ]. J Biol Chem, 2009,284 ( 33 ) :22048 - 58.
  • 6Lamalice L, Le Boeuf F, Huot J. Endothelial cell migration during angiogenesis [ J ]. Circ Res, 2007,100 (6) : 782 - 94.
  • 7Andrae J, Gallini R, Betshohz C. Role of platelet-derived growth factors in physiology and medicine [ J ] Genes Dev, 2008,22 (10) :1276 -312.
  • 8Braun K R, DeWispelaere A M, Bressler S L, et al. Inhibition of PDGF-B induction and cell growth by syndecan-1 involves the ubiquitin and SUMO-1 ligase, Topors [ J]. PLoS One, 2012,7 (8) :e43701.
  • 9Larsen M ,Tremblay M L,Yamada K M. Phosphatases in ee|l-ma- trix adhesion and migration [ J ]' Nat Rev Mol Cell Biol, 2003,4 (9) :700 - 11.
  • 10Lilien J, Balsamo J. The regulation of cadherin-mediated adhesion by tyrosine phosphorylation/dephosphorylation of -catenin [ J ]. Curt Opin Cell Biol, 2005, 17(5) :459 -65.

二级参考文献12

  • 1Folkman J. Tumor angiogenesis : therapeutic implications [ J]. NEngl J Med,1971,285(21):1182-6.
  • 2Folkman J. Angiogenesis[ J]. Annu Rev Med,2006 ,57 :1 - 18.
  • 3Shimanuki Y, Takahashi K, Cui R, et al. Role of serum vascularendothelial growth factor in the prediction of angiogenesis andprognosis for non - small cell lung cancer [ J]. Lung,2005,183(1):29 -42.
  • 4Sabrkhany S,Griffioen A W, Oude Egbrink M G. The role ofblood platelets in tumor angiogenesis[ J]. Biochim Biophys Acta,2011,1815(2):189 -96.
  • 5Klement G L,Yip T T, Cassiola F, et al. Platelets actively se-quester angiogenesis regulators[ J]. Blood,2009,113(12) :2835-42.
  • 6Peterson J E,Zurakowski D,Italiano J E,et al. Normal ranges ofangiogenesis regulatory proteins in human platelets[ J] . Am J He-matol,2010,85(7) :487 -93.
  • 7Zaslavsky A, Baek K H, Lynch R C, et al. Platelet-derivedthrombospondin-1 is a critical negative regulator and potential bio-marker of angiogenesis[ J]. Blood,2010,115(22) :4605 - 13.
  • 8Wendum D, Boelle P Y, Rigau V,et al. Mucinous colon carcino-mas with microsatellite instability have a lower microvessel densityand lower vascular endothelial growth factor expression [ J]. Vir-chows Arch,2003,442(2) :111 -7.
  • 9Hamano Y, Zeisberg M,Sugimoto H,et al. Physiological levels oftumstatin,a fragment of collagen IV alpha3 chain,are generatedby MMP-9 proteolysis and suppress angiogenesis via alphaV beta3integrin[ J]. Cancer Cell,2003 ,3(6) :589 -601.
  • 10Brawer M K. Quantitative microvessel density. A staging and prog-nostic marker for human prostatic carcinoma[ J]. Cancer, 1996,78(2) :345 -9.

共引文献5

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部